Literature DB >> 24632330

Massive exudative retinal detachment following photodynamic therapy for retinal hemangioma in von Hippel-Lindau Syndrome.

Yao Chen1, Hong Liu1, Kun Zhang1, Ling Gao2.   

Abstract

Photodynamic therapy (PDT) is a common treatment on retinal capillary hemangioma. We applied PDT to a patient with von Hippel-Lindau(VHL) syndrome and she developed severe massive exudative retinal detachment the next day, which is a rare complication for PDT. After intraocular anti-VEGF agent and peribulbar dexamethasone several times to the patient, her subretinal fluid disappeared and hemangiomas atrophied. Treatment with Anti-VEGF agent and corticosteroid is effective for such complication.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Photodynamic therapy; Retinal detachment; Retinal hemangioma

Mesh:

Substances:

Year:  2014        PMID: 24632330     DOI: 10.1016/j.pdpdt.2014.02.013

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  4 in total

1.  Von Hippel-Lindau "Black Forest" mutation inherited in a large Chinese family.

Authors:  Peihua Liu; Feizhou Zhu; Minghao Li; Daud Athanasius Dube; Qianqian Liu; Cikui Wang; Qiao Xiao; Liang Zhang; Shuai Gao; Zhuolin Li; Bo Zhang; Jing Liu; Longfei Liu; Xiang Chen
Journal:  Gland Surg       Date:  2019-08

2.  Massive exudative retinal detachment following photodynamic therapy and intravitreal bevacizumab injection in retinal capillary hemangioma.

Authors:  Hyeong Min Kim; Kyu Hyung Park; Se Joon Woo
Journal:  Korean J Ophthalmol       Date:  2015-04

Review 3.  Juxtapapillary retinal capillary hemangioma: new therapeutic strategies.

Authors:  Andrea Saitta; Michele Nicolai; Alfonso Giovannini; Cesare Mariotti
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

4.  Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.

Authors:  Virginia Albiñana; Rosa María Jiménez Escribano; Isabel Soler; Luis Rodríguez Padial; Lucia Recio-Poveda; Karina Villar Gómez de Las Heras; Luisa María Botella
Journal:  Orphanet J Rare Dis       Date:  2017-06-29       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.